Pharmafile Logo

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear…

“…Of course, we also need to consider where (from who) the information is coming from. Doctors, pharmacists, and other health experts are more trusted than life science CEOs, government leaders, and journalists. Among healthcare institutions, academic medical research institutions are the most trusted. For Pharma, this means that establishing authentic relationships with trusted and approachable physicians, pharmacists, nurses, and academics should be a top priority. In addition to traditional key opinion leaders (KOLs), digital opinion leaders (DOLs)–an emerging group of stakeholders for Pharma to engage with–are well-positioned to share scientific data with the general public. 

Pharma teams should work directly with KOLs and DOLs, as well as with patients and caregivers, to design public-facing videos, websites, handouts, and educational campaigns in order to get the right messages across. When events that might erode public trust do occur, be open and honest with your advisors and get their input on how to respond to negative press in a transparent and sincere manner.”

Read the full article at https://www.impetusdigital.com/2022/05/10/trust-and-transparency-in-pharma/

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

The Future of eHealth: Contactless Health Monitoring

Laurence Pearce, CEO & Founder of Xim Ltd, creators of Lifelight®, discusses the need for personal health monitoring; traditional issues associated with population health screening; AI, machine learning, and computer...

Making Digital Trust and Privacy Accessible to Everyone

Mike Cook, CEO of IDENTOS, shares how his company is making digital trust and privacy accessible for patients, healthcare providers, payers, organizations, and connected devices. He also discusses “smart cities”...

Disrupting Cell Engineering with Non-Viral Modalities

Jessica Schwaber, Scientific Director, Cell & Gene Therapy, Avectas, explores her company’s unique cell engineering platform, the recent shift in cell & gene therapy commercial needs, current barriers to realizing...

Congress eHuddle & Debrief Session: A Customer Story

How a Pharma team hosted daily MSL “eHuddles” during ASCO 2021 plus a post-congress debrief session using our asynchronous platform.

Healthcare Access and Payment Reform in the US

Chris Saxman, Senior Healthcare Executive, Head of Product Strategy at UCM Digital Health, shares his thoughts on the US healthcare system, including its flaws and how to fix it; the...

Advancing Drug Discovery with Structured and Intelligent Data

Michael Wilson and Craig Knox, co-founders of DrugBank, discuss how their comprehensive drug database can be used together with AI and machine learning for drug discovery and repurposing, clinical research,...

Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost

Lydia Zeller, CEO at Kiio, explores digital therapeutics, healthcare innovation, and Kiio’s innovative and personalized solutions for musculoskeletal (MSK) pain. She also shares her key leadership lessons and predictions for...

Accelerating Drug Development Timelines with Big Data Analytics

Barış Erdoğan, CEO of Clinerion, shares how medical data informatics and real-world EHR data can be used to improve the efficiency and effectiveness of patient searches, identification, and recruitment; clinical...

Health literacy in the time of COVID-19

In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...

Helping Caregivers Stay Organized, Secure, and Informed

Audrey Bond, Founder & CEO of Vaultt, discusses her inspiration behind founding the company, how Vaultt is revolutionizing data-sharing in Canada, common biosecurity and data privacy concerns, her experience with...